Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -433,680 | -319,856 | -200,737 | -97,574 | -276,336 |
| Depreciation Amortization | -36,265 | -26,313 | -15,860 | -6,978 | -3,895 |
| Accounts receivable | 57 | 57 | 57 | 57 | 1,693 |
| Accounts payable and accrued liabilities | 4,347 | 413 | -1,310 | -1,903 | 243 |
| Other Working Capital | 11,931 | 22,356 | 19,630 | -11,262 | 5,757 |
| Other Operating Activity | 67,791 | 48,583 | 33,457 | 17,031 | 44,532 |
| Operating Cash Flow | $-385,819 | $-274,760 | $-164,763 | $-100,629 | $-228,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -157,404 | -250,643 | -279,582 | -26,777 | -585,480 |
| PPE Investments | -2,917 | -2,118 | -1,489 | -714 | -915 |
| Investing Cash Flow | $-160,321 | $-252,761 | $-281,071 | $-27,491 | $-586,395 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 488,101 | 463,767 | 460,904 | 442,570 | 856,218 |
| Other Financing Activity | -4,728 | -261 | -57 | -119 | -441 |
| Financing Cash Flow | $483,373 | $463,506 | $460,847 | $442,451 | $855,777 |
| Beginning Cash Position | 248,590 | 248,590 | 248,590 | 248,590 | 207,214 |
| End Cash Position | 185,823 | 184,575 | 263,603 | 562,921 | 248,590 |
| Net Cash Flow | $-62,767 | $-64,015 | $15,013 | $314,331 | $41,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -385,819 | -274,760 | -164,763 | -100,629 | -228,006 |
| Capital Expenditure | -2,917 | -2,118 | -1,489 | -714 | -915 |
| Free Cash Flow | -388,736 | -276,878 | -166,252 | -101,343 | -228,921 |